Dr. James W. Donovan, MD

Dr. Donovan practices at Milauskas Eye Institute in La Quinta, California.

Dr. Donovan's NPI, 1952369399, was assigned on May 3, 2006. Dr. Donovan graduated from Loyola University Chicago Stritch School of Medicine in 1993. Dr. Donovan holds California license G84806.

Dr. Donovan's primary practice is Milauskas Eye Institute, at 78560 Hwy 111, La Quinta, CA 92253-2067. The practice phone is (760) 564-3887.

Dr. Donovan's primary practice is Milauskas Eye Institute in La Quinta, California. Dmand AI also links Dr. Donovan to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donovan practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Donovan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Donovan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Donovan's licenses on file in 3 states: California, Oregon and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Donovan treats.

CMS data shows 4,594 Medicare services from Dr. Donovan across 19 procedure codes in 2024, for 2,048 Medicare patients. Medicare paid $455,646 for them.

CMS counts 2,048 Medicare patients who saw Dr. Donovan in 2024. The largest group is 75 to 84, with 959 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Donovan's median patient age at 76, with 54% women.

In 2024, Dr. Donovan wrote 1,876 Medicare Part D claims for 676 patients. 47% of them were for generic drugs. CMS names the drug for 1,773 of them, across 18 drugs with 11 or more claims each, at $97,174 in total drug cost. In 2023, CMS named 1,416 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Donovan for performance year 2024, reported as part of a group. Dr. Donovan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 669 procedures of cataract surgery by Dr. Donovan, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Donovan in 2018. 2018 was the busiest year, with 2. Dr. Donovan has published most often in Pilot Feasibility Stud.

CMS Open Payments shows 88 general payments to Dr. Donovan from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Alcon Laboratories Inc paid the most, $2,907.

Dmand AI lists 1 award for Dr. Donovan, most recently CMS Stage 1 EHR in 2013.

Dr. Donovan graduated from Loyola University Chicago Stritch School of Medicine in 1993. Dr. Donovan is a member of AAO and ASCRS.

Dr. Donovan is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.